The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Enfortumab vedotin plus pembrolizumab in metastatic urothelial carcinoma: First results on outcomes and safety in a German multicenter real-world patient cohort (GUARDIANS).
 
Stefanie Zschaebitz
Honoraria - Amgen; Astellas Pharma; Bayer; BMS GmbH & Co. KG; Eisai Germany; Ipsen; Janssen Oncology; Merck Serono; MSD Oncology; Novartis; Pfizer (Inst)
Consulting or Advisory Role - Amgen; Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai; EUSA Pharma; Gilead Sciences; Ipsen; Merck; MSD Oncology; Pfizer (Inst); Roche; Sanofi/Aventis (Inst)
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; BMS GmbH & Co. KG; Ipsen; Janssen Oncology; Merck; Pfizer
 
Jozefina Casuscelli
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)
Expert Testimony - Astellas Pharma; Janssen Cilag; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Janssen Oncology; Merck KGaA; Pfizer
 
Thomas Büttner
Honoraria - Astellas Pharma; medac pharma
Travel, Accommodations, Expenses - Ipsen; MSD
 
Christopher Darr
Stock and Other Ownership Interests - Bayer
Honoraria - Bayer; Ipsen; Janssen; MSD
Consulting or Advisory Role - Bayer; Ipsen; Janssen
Research Funding - Deutsche Forschungsgemeinschaft (Inst)
Travel, Accommodations, Expenses - Bayer; Ipsen; Janssen; Xeos medical
 
Anna-Lisa Volk
No Relationships to Disclose
 
Martin Hennig
No Relationships to Disclose
 
Nina Holzwarth
No Relationships to Disclose
 
Friedemann Zengerling
Honoraria - Amgen; Apogepha; Astellas Pharma; Bayer/Vital; Ipsen; Janssen; Merck; Pfizer
Consulting or Advisory Role - Apogepha; Astellas Pharma; AstraZeneca; Bayer Health; Bristol-Myers Squibb; IPSEN; Janssen; Merck; Merck Sharp & Dohme; Novartis; Onkowissen; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer Health; IPSEN; Janssen; Pfizer
 
Muammar Dib
No Relationships to Disclose
 
Katrin Schlack
Honoraria - AAA HealthCare; Amgen (Inst); Astellas Pharma; AstraZeneca; Bayer Germany; Eisai Germany; Fosanis; Ipsen; Janssen; Merck Serono; MSD; Novartis; Pfizer
Consulting or Advisory Role - Apogepha; Bayer; BMS GmbH & Co. KG; Ipsen; Janssen; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Ipsen; Janssen; Pfizer
 
Pia Paffenholz
Honoraria - Apogepha; Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Ipsen; Janssen; Merck; Novartis
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Ipsen; Janssen; Medac; Merck
 
Julia Heinzelbecker
No Relationships to Disclose
 
Subhajit Mandal
No Relationships to Disclose
 
Frederik Wessels
Honoraria - Bayer Germany; Ipsen; Johnson & Johnson/Janssen; Medac; MSD Oncology
Consulting or Advisory Role - Adon Health; Astellas Pharma; AstraZeneca; Johnson & Johnson/Janssen
 
Daniel Seidl
No Relationships to Disclose
 
Eva Erne
Travel, Accommodations, Expenses - Pfizer
 
Susan Foller
Honoraria - Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Procept BioRobotics; Roche
Consulting or Advisory Role - Ipsen; Merck/Pfizer; MSD; Roche
 
Alexander Höllein
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen Oncology; Sanofi
Travel, Accommodations, Expenses - Abbvie; Janssen Oncology
 
Viktor Grünwald
Employment - University Hospital Essen
Stock and Other Ownership Interests - AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Genmab; MSD
Honoraria - Advanced Accelerator Applications/Novartis; Amgen; Apogepha; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Merck Serono; MSD Oncology; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Cureteq; Debiopharm Group; Eisai; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Oncorena; PCI Biotech; Pfizer; Synthekine
Research Funding - Amgen (Inst); Bicycle Therapeutics (Inst); BMS (Inst); Gilead Sciences (Inst); Ipsen (Inst); MSD Oncology (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen; Merck Serono; Pfizer
 
Marco Julius Schnabel
Stock and Other Ownership Interests - BioNTech SE
Honoraria - Apogepha; Astellas Pharma; AstraZeneca; AstraZeneca (Inst); Bayer; Gilead Sciences; Ipsen; Ipsen (Inst); Johnson & Johnson/Janssen; Johnson & Johnson/Janssen (Inst); Medac; Merck Serono; MSD Oncology; MSD Oncology (Inst); Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bayer; Bayer; Gilead Sciences; Ipsen; Johnson & Johnson/Janssen; MSD Oncology; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Johnson & Johnson/Janssen; Pfizer
 
GUARDIANS
No Relationships to Disclose